Vulvar Disease in Nigeria Observational Study

Updated 06/21/2024

Status Recruiting

Clinical Trial Summary

Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05890092
Study type	Observational [Patient Registry]
Source	KDRS ltd
Contact
Status	Recruiting
Phase
Start date	May 3, 2023
Completion date	November 30, 2026

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05478746` - Effects of Flourish HEC on Localized Provoked Vulvodynia	N/A
	Not yet recruiting	`NCT06070454` - Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions	N/A
	Completed	`NCT00004316` - Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis	Phase 1/Phase 2
	Recruiting	`NCT05592626` - A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors	Phase 1/Phase 2
	Recruiting	`NCT02858310` - E7 TCR T Cells for Human Papillomavirus-Associated Cancers	Phase 1/Phase 2
	Terminated	`NCT03444727` - Treatment Prior to Injection and Biopsy of the Vulva	N/A
	Recruiting	`NCT06075264` - Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)	Phase 2
	Completed	`NCT00496184` - Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis	Phase 3
	Recruiting	`NCT00119886` - Botox on Vulvar Vestibulitis	Phase 4
	Active, not recruiting	`NCT03792516` - Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)	Phase 1